Latest other current assets for ZYME: $18M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), ZYME shows a other current assets of $18M. That compares with $10B in the prior-year period — down 99.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ZYME's other current assets is now $18M (was $10B) — a 99.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zymeworks BC is outperforming or lagging.
Tracking ZYME's other current assets over time shows whether Zymeworks BC is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $10B in the prior-year period — down 99.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current assets page, Stockcircle has Zymeworks BC's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $18M) with ownership activity and broader fundamentals.
Zymeworks BC's other current assets is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.